Despite liver injury in patients infected with severe acute respiratory syndrome (SARS)
coronavirus (CoV)-2 (SARS-CoV-2) is associated with prolonged hospitalization, and liver …

Background & Aims Liver enzyme abnormalities are common in patients with coronavirus
disease 2019 (COVID-19). Whether or not severe acute respiratory syndrome coronavirus 2 …

Methods A systematic literature search of indexed databases including, PubMed, Medline,
and Embase databases from inception to 14 April 2020, was used to identify studies that …

Globally, the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2 virus) has
been a major cause for significant morbidity and mortality. Since the start of the pandemic …

Emerging evidence suggest association of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection with the development of many liver abnormalities. The overarching …

OBJECTIVE: Liver involvement of SARS-CoV-2 infection has been reported in several
papers, but without homogeneous findings. We aimed to systematically review the …

Background & Aims Some patients with SARS-CoV-2 infection have abnormal liver function.
We aimed to clarify the features of COVID-19-related liver damage to provide references for …

We have read with interest the recent study by Qi et al. 1 Currently, the impact of COVID-19
on the liver remains unexplored. Although majority of patients with COVID-19 have …

Background The incidence of elevated liver chemistries and the presence of pre‐existing
chronic liver disease (CLD) have been variably reported in COVID‐19. Aims To assess the …

Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is a novel coronavirus
that causes coronavirus disease 19 (COVID‐19), which has infected millions of people …